OCREVUS Patient and Financial Resources

Find the right assistance option for your patients.

  • Is your patient insured?

  • Does your patient have commercial insurance?

    What does this mean?
  • Has your patient already been referred to a Genentech co-pay card and is either ineligible or no longer receiving assistance?

  • Has your patient already been referred to an independent co-pay assistance foundation and is either ineligible for assistance or no longer receiving it?

  • Is the patient using OCREVUS for the approved indication?

OCREVUS Co-pay Program 

This program may be able to help reduce your eligible patients’ out-of-pocket expenses associated with their prescriptions.


Click here to learn more about the OCREVUS Co-pay Program.

Independent Co-pay Assistance Foundations

If patients need help with their medication co-pays, OCREVUS Access Solutions can refer them to an independent co-pay assistance foundation supporting their disease state.


Click here to learn more about independent co-pay assistance foundations.


GATCF helps qualified patients receive their medicine free of charge. To qualify for free medicine from GATCF, patients need to meet specific criteria.


Click here to learn more about GATCF.

OCREVUS pat card icon


Genentech offers the OCREVUS Co-pay Program to help eligible patients with the out-of-pocket costs associated with their prescription.*

OCREVUS pat magnifier icon


For eligible patients with commercial or public insurance, OCREVUS Access Solutions offers referrals to independent foundations.


The Genentech® Access to Care Foundation (GATCF)

GATCF helps eligible patients who meet specific criteria receive Genentech medicines free of charge.

*In order to be eligible for the OCREVUS Co-pay Program, the patient must confirm that they meet the eligibility criteria and agree to the rules set forth in the terms and conditions for the program. Please visit OCREVUS.com/copay for the full list of terms and conditions.
Genentech does not influence or control the operations or eligibility criteria of any independent co-pay assistance foundation and cannot guarantee co-pay assistance after a referral from OCREVUS Access Solutions. The foundations to which we refer patients are not exhaustive or indicative of Genentech's endorsement or financial support. There may be other foundations to support the patient's disease state.

View the Access Roadmap for an overview of the services and support Genentech offers from clinical decision through infusion.

OCREVUS Access Solutions

Genentech is committed to helping patients access our medicines, regardless of their ability to pay.

OCREVUS Access Solutions provides reliable, effective access and reimbursement services to assist your patients and practice after OCREVUS has been prescribed.

To enroll your patient in OCREVUS Access Solutions:

  • You complete and sign the Statement of Medical Necessity (SMN)
    • The SMN is a form with patient, insurance and prescription information used when OCREVUS Access Solutions contacts a patient’s health insurance plan to determine his or her coverage
  • Your patient signs and dates the Patient Authorization and Notice of Release of Information (PAN)
    • The PAN is a form signed and dated by your patient giving written permission for OCREVUS Access Solutions to discuss his or her case with you and the patient’s health insurance plan
  • Submit these 2 forms to OCREVUS Access Solutions